What is Beckwith-Wiedemann Syndrome

TL;DR: Beckwith-Wiedemann Syndrome (BWS) is a rare congenital overgrowth disorder characterized by an increased risk of childhood tumors and distinctive physical features, such as macroglossia (enlarged tongue) and abdominal wall defects. It is caused by genetic or epigenetic changes on chromosome 11p15, a region that regulates fetal growth.

What is Beckwith-Wiedemann Syndrome?

Beckwith-Wiedemann Syndrome is a complex genetic condition that affects many parts of the body. It is often described as an "overgrowth syndrome" because infants with the condition are frequently larger than average at birth (macrosomia) and may experience rapid growth during early childhood. Because Beckwith-Wiedemann Syndrome involves the dysregulation of genes responsible for growth, it can present with a wide spectrum of symptoms that vary significantly from person to person. Within the DiseaseMaps.org community, we currently support 241 individuals living with this diagnosis, highlighting the diverse ways this condition manifests in daily life.

Which body systems are affected by Beckwith-Wiedemann Syndrome?

The clinical presentation of Beckwith-Wiedemann Syndrome is highly variable, but several key features are commonly observed. The condition affects developmental processes, leading to both physical and metabolic differences. Common clinical findings include:

• Macroglossia: An enlarged tongue that may interfere with breathing, feeding, and speech.


• Abdominal wall defects: Conditions such as omphalocele (where organs protrude through the belly button), umbilical hernia, or diastasis recti.


• Hemihyperplasia: A condition where one side of the body or a specific limb grows larger than the other.


• Metabolic disturbances: Persistent low blood sugar (hypoglycemia) in the newborn period, which requires careful monitoring.


• Increased tumor risk: A predisposition to developing embryonal tumors, most notably Wilms tumor (kidney) and hepatoblastoma (liver), usually occurring in early childhood.

How common is Beckwith-Wiedemann Syndrome and who is affected?

Beckwith-Wiedemann Syndrome is estimated to occur in approximately 1 in 10,300 to 1 in 13,700 live births worldwide. It affects both males and females equally and is found in all ethnic and geographic populations. While the majority of cases are sporadic (occurring in families with no prior history), some cases can be hereditary, making genetic counseling a vital component of family planning and diagnosis.

What causes Beckwith-Wiedemann Syndrome?

At its core, Beckwith-Wiedemann Syndrome is caused by abnormal regulation of genes on chromosome 11p15.5. These genes are "imprinted," meaning that their expression depends on whether they are inherited from the mother or the father. When this imprinting is disrupted—whether through DNA methylation defects, uniparental disomy, or chromosomal rearrangements—the body loses its "brakes" on growth, leading to the characteristic overgrowth and health risks associated with the syndrome.

How is this condition differentiated from others?

Clinicians differentiate Beckwith-Wiedemann Syndrome from other overgrowth syndromes (such as Sotos syndrome or Simpson-Golabi-Behmel syndrome) by evaluating the specific constellation of symptoms—specifically the combination of abdominal wall defects and macroglossia—and confirming the diagnosis through specialized molecular genetic testing of the 11p15 region.

Next steps

• Consult a Geneticist: Meet with a clinical geneticist to discuss molecular testing and personalized tumor surveillance protocols.


• Assemble a Care Team: Engage a multidisciplinary team, including pediatric oncologists, endocrinologists, and surgeons, to manage specific symptoms.


• Join the Community: Connect with the 241 members on DiseaseMaps.org to share experiences and find support from others navigating the same journey.


• Monitor Growth and Health: Adhere strictly to the recommended screening schedule for ultrasounds and blood work to detect potential health issues early.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH GARD: Beckwith-Wiedemann syndrome (rarediseases.info.nih.gov)


• Orphanet: Beckwith-Wiedemann syndrome (orpha.net)


• OMIM: Beckwith-Wiedemann Syndrome; BWS (omim.org/entry/130650)


• How2BWS: Patient-centered resources for families (how2bws.com)